Gene · 53947
Papers2,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fabry disease cardiomyopathy: A state-of-the-art review. | Prog Cardiovasc Dis | 2025 | 40840785 | PubTator, text mining | PubMed |
| Expression of a human Gb3/CD77 synthase in insect and human cells: comparison of activity and glycosylation. | Protein Expr Purif | 2025 | 40835153 | PubTator, text mining | PubMed |
| Molecular basis of ligand binding and receptor activation at the human A3 adenosine receptor. | Nat Commun | 2025 | 40825947 | PubTator, text mining | PubMed |
| An epigenome-wide association study in the case-control study to explore early development identifies differential DNA methylation near ZFP57 as associated with autistic traits. | J Neurodev Disord | 2025 | 40819066 | PubTator, text mining | PubMed |
| Super-resolution triple-resonance NMR spectroscopy for the sequential assignment of proteins. | Sci Adv | 2025 | 40815649 | PubTator, text mining | PubMed |
| Globotriaosylceramide Gb3 Influences Wound Healing and Scar Formation by Orchestrating Fibroblast Heterogeneity. | Adv Sci (Weinh) | 2025 | 40810720 | PubTator, text mining | PubMed |
| Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression. | Int J Mol Sci | 2025 | 40806187 | PubTator, text mining | PubMed |
| Lysosomal free sialic acid storage disorder iPSC-derived neural cells display altered glycosphingolipid metabolism. | Sci Rep | 2025 | 40804080 | PubTator, text mining | PubMed |
| Feasibility of using saliva for Cytomegalovirus detection and genotyping in pediatric hematopoietic stem cell transplant recipients. | Acta Odontol Latinoam | 2025 | 40741805 | PubTator, text mining | PubMed |
| A New Next-Generation Sequencing Approach in Human Cytomegalovirus for the Identification of Antiviral Resistance Mutations and Genotypic Classification. | J Med Virol | 2025 | 40736009 | PubTator, text mining | PubMed |
| Comparative Evaluation of AAV8 and AAV9 Gene Therapy in Fabry Knockout (Gla-/y) and Symptomatic (G3STg/+Gla-/y) Murine Models. | Genes (Basel) | 2025 | 40725422 | PubTator, text mining | PubMed |
| Isomerization of photo-Gb3 in phase-separated pore-spanning membranes alters Shiga toxin organization. | Biophys J | 2025 | 40653708 | PubTator, text mining | PubMed |
| Shiga toxins from enterohemorrhagic Escherichia coli and anti-GB3 antibody as novel agents against triple negative breast cancer. | Chem Biol Interact | 2025 | 40617562 | PubTator, text mining | PubMed |
| A case report of a rare p phenotype individual and a review of molecular biological analysis of p phenotype in the Chinese population. | Transfus Med | 2025 | 40583569 | PubTator, text mining | PubMed |
| Molecular Diplomacy of Lipids in the War of Immunity: Bridging Rare and Common Disease Mechanisms. | Int J Mol Sci | 2025 | 40565032 | PubTator, text mining | PubMed |
| Maturation of Lysosomal α-Galactosidase A and Implications for Fabry Disease. | Nephron | 2025 | 40527302 | PubTator, text mining | PubMed |
| A4GALT-targeting siRNA lipid nanoparticles ameliorate Fabry disease phenotype: Greater efficacy in endothelial cells than in podocytes. | Mol Ther Nucleic Acids | 2025 | 40520362 | PubTator, text mining | PubMed |
| Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centre. | Mol Genet Metab Rep | 2025 | 40485669 | PubTator, text mining | PubMed |
| Fabry disease - a risk factor for renal cell cancer? - case series. | Mol Genet Metab | 2025 | 40483913 | PubTator, text mining | PubMed |
| Tailor-made red cells: the long road towards blood safety. | Haematologica | 2025 | 40438987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53947/papers?page=4